Pyranopyridone alkaloids, methods for preparing the same and use thereof in the preparation of anti-tumor drugs
By isolating and purifying novel pyranopyranopyridone alkaloid compounds 1-3 from the fermentation culture of Penicillium sp. SCSIO 41320, the problem of insufficient targeted therapy in the treatment of small cell lung cancer has been solved, and significant anti-tumor activity has been achieved, which promotes the development of marine microbial drug resources.
Patent Information
- Application Number
- CN202511391411.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-26
- Publication Date
- 2026-06-09
- Estimated Expiration
- 2045-09-26
AI Technical Summary
Existing targeted therapies are not effective enough in the treatment of small cell lung cancer (SCLC), there is a lack of significant new anti-tumor drugs, and the pharmacological potential of pyranopyridone alkaloids has not been fully utilized.
Novel pyranopyridone alkaloid derivative compounds 1, 2, and 3 were isolated and prepared from the fermentation culture of Penicillium sp. SCSIO 41320. They were purified by multi-step column chromatography and high-performance liquid chromatography with gradient elution to obtain compounds with significant antitumor activity, which can be used to prepare drugs against small cell lung cancer.
Compounds 1-3 exhibit significant inhibitory activity against small cell lung cancer cell lines H446, H1048, H69AR, and H82, with low IC50 values, demonstrating good antitumor activity and possessing the potential to serve as lead compounds for the development of antitumor drugs, thus promoting the development of marine microbial drug resources.